Article(id=1322631254516810415, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631228000424183, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.18.017, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1773936000000, receivedDateStr=2026-03-20, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793269464377, onlineDateStr=2026-10-29, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793269464377, onlineIssueDateStr=2026-10-29, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793269464377, creator=13701087609, updateTime=1793269464377, updator=13701087609, issue=Issue{id=1322631228000424183, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='18', pageStart='7073', pageEnd='7500', issueExtLink='null', onlineDate='null', pubDate='1790524800000', pubDateStr='2026-09-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793269458054, creator='13701087609', updateTime=1793269548245, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322631606339228314, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631228000424183, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322631606339228315, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631228000424183, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=7281, endPage=7294, ext={EN=ArticleExt(id=1322631254848160433, articleId=1322631254516810415, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Preparation and in vitro anti-tumor evaluation of targeted nanoparticles co-loaded with homohardenine/triptolide, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To prepare prostate specific membrane antigen (PSMA)-targeting peptide-modified lipid-polymer nanoparticles co-loaded with homoharringtonine and triptolide (HHT/TPL-PSMA-Lips), optimize its preparation process, and evaluate its in vitro anti-prostate cancer activity. Methods The solubility and oil-water partition coefficient (lgP) of HHT and TPL were determined, and PSMA-targeting peptide-modified PEGylated phospholipids were synthesized. HHT/TPL-PSMA-Lips was prepared by the emulsification-solvent evaporation method, and the formulation was optimized using central composite design-response surface methodology (CCD-RSM). Indicators including particle size, ζ potential, and encapsulation efficiency were investigated. The in vitro release behavior of the formulation in different media was evaluated. MTT assay and flow cytometry were used to assess the in vitro inhibitory effect and apoptosis-inducing activity of the nanoparticles on prostate cancer cells, while cell uptake assay was performed to verify the tumor cell targeting efficiency of the nanoparticles. Results HHT and TPL showed low solubility in various media and strong lipophilicity. The molecular weight of the synthesized PSMA-targeting peptide-modified PEGylated phospholipids was 4 643.8. HHT/TPL-PSMA-Lips prepared with the optimal formulation exhibited uniform particle size, with an average particle size of (209.12 ± 3.24) nm, a ζ potential of (-34.4 ± 2.5) mV, and a comprehensive encapsulation efficiency of (81.20 ± 0.40)% [HHT (80.73 ± 0.86)%, TPL (82.00 ± 0.40)%]. In vitro release experiments demonstrated that HHT/TPL-PSMA-Lips could effectively improve the solubility of HHT and TPL, and exhibite a certain pH-responsive release property. Cell experiments showed that the HHT/TPL combined administration group displayed stronger inhibitory effect on prostate cancer cells and better apoptosis-inducing activity than the single drug groups. HHT/TPL-Lips enhanced the anti-tumor activity, and the targeted modified nanoparticles (HHT/TPL-PSMA-Lips) showed the strongest inhibitory effect on prostate cancer cells. Cell uptake assay indicated that modification with PSMA-targeting peptide could effectively enhance the cellular uptake of the nanoformulation in tumor cells. Conclusion The prepared HHT/TPL-PSMA-Lips not only solves the solubility problem of the drugs but also significantly enhances tumor targeting and anti-tumor efficacy, providing a new approach for the development of new traditional Chinese medicine formulations for the treatment of prostate cancer., authors=SUN Chengwen1, WANG Shuai2, ZHANG Minhao2, LI Wenchao3, WANG Yanchun4, GU Peng2, authorsList=SUN Chengwen, WANG Shuai, ZHANG Minhao, LI Wenchao, WANG Yanchun, GU Peng, authorCompany=1 Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi 214062, China;
2 Department of Urology, Xishan People's Hospital of Wuxi City, Wuxi 214105, China;
3 Department of Urology, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China;
4 The Rehabilitation Center of the Third Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450003, China, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322631254760080048, articleId=1322631254516810415, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=共载高三尖杉酯碱/雷公藤甲素的靶向纳米粒制备及体外抗肿瘤评价, columnId=1304140189132149234, journalTitle=中草药, columnName=药剂与工艺, runingTitle=null, highlight=null, articleAbstract=目的 制备共载高三尖杉酯碱(homoharringtonine,HHT)和雷公藤甲素(triptolide,TRL)-前列腺特异性膜抗原(prostate specific membrane antigen,PSMA)靶向肽修饰脂质-聚合物纳米粒(PSMA-targeting peptide-modified lipid-polymer nanoparticles co-loaded with HHT and TRL,HHT/TRL-PSMA-Lips),优化其制备工艺,并进行体外抗前列腺癌肿瘤作用评价。方法 测定HHT与TPL的溶解度及油水分配系数(lgP),合成PSMA靶向肽修饰PEG化磷脂。采用乳化-溶剂挥发法制备HHT/TPL-PSMA-Lips,采用中心复合设计-响应面法(central composite design-response surface methodology,CCD-RSM)优化处方,并考察其粒径、ζ电位、包封率等指标。考察制剂在不同介质中的体外释放行为。并采用MTT法、流式细胞术考察纳米粒对前列腺癌细胞的体外抑制及诱导凋亡作用,采用细胞摄取实验考察纳米粒的肿瘤细胞靶向效果。结果 HHT与TPL在不同介质中的溶解度均较低,亲脂性较强。合成PSMA靶向肽修饰PEG化磷脂的相对分子质量为4 643.8。采用最优处方的制备的HHT/TPL-PSMA-Lips粒径均一,平均粒径为(209.12±3.24)nm,ζ电位为(-34.4±2.5)mV,综合包封率为(81.20±0.40)%[HHT(80.73±0.86)%,TPL(82.00±0.40)%],体外释放实验证明,HHT/TPL-PSMA-Lips可有效提高HHT和TPL的溶解度,并具有一定的pH响应性释放效果。细胞实验表明,HHT/TPL联合给药组显示出高于单一药物组的前列腺肿瘤细胞抑制作用,及诱导凋亡效果,HHT/TPL-Lips可提高抗肿瘤活性,靶向修饰的纳米粒HHT/TPL-PSMA-Lips显示出对前列腺肿瘤细胞最强的抑制效果。细胞摄取实验表明,PSMA靶向肽的修饰可有效提高纳米制剂在肿瘤细胞的摄取。结论 制备的HHT/TPL-PSMA-Lips不仅可解决药物的溶解性问题,并可显著提升肿瘤靶向作用以及抗肿瘤效果,为中药新制剂用于前列腺癌的治疗提供了新思路。, authors=孙承文1, 王帅2, 章民昊2, 李文超3, 王艳春4, 顾鹏2, authorsList=孙承文, 王帅, 章民昊, 李文超, 王艳春, 顾鹏, authorCompany=1 江南大学附属医院 泌尿外科, 江苏 无锡 214062;
2 无锡市锡山人民医院 泌尿外科, 江苏 无锡 214105;
3 东南大学附属中大医院 泌尿外科, 江苏 南京 210009;
4 河南中医药大学第三附属医院 康复中心, 河南 郑州 450003, correspAuthors=顾鹏, authorNote=孙承文: 孙承文,男,副主任医师,研究方向为泌尿系肿瘤。E-mail:awen1698@126.com, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=6P9gRXjuJJyU/8UO3KVSHQ==, pdfFileSize=1731643, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=国家自然科学基金资助项目 (U1804181); 河南省中医药专项课题 (2024ZY2134); 无锡市卫生健康委科研青年项目 (Q202307); 无锡市卫生健康委中青年后备拔尖人才项目 (HB2023117); 中国博士后科学基金第73批面上资助 (2023M730572))}, authors=[Author(id=1324152561338561516, tenantId=1146029695717560320, journalId=null, articleId=1322631254516810415, orderNo=null, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=null, authorType=null, ext={EN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1322631254516810415, authorId=1324152561338561516, language=EN, stringName=SUN Chengwen, WANG Shuai, ZHANG Minhao, LI Wenchao, WANG Yanchun, GU Peng, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1322631254516810415, authorId=1324152561338561516, language=CN, stringName=孙承文, 王帅, 章民昊, 李文超, 王艳春, 顾鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=null)], keywords=[Keyword(id=1322634667455533792, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=CN, orderNo=1, keyword=高三尖杉酯碱), Keyword(id=1322634667522642657, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=CN, orderNo=2, keyword=雷公藤甲素), Keyword(id=1322634667614917346, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=CN, orderNo=3, keyword=前列腺癌), Keyword(id=1322634667774300899, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=CN, orderNo=4, keyword=靶向纳米粒), Keyword(id=1322634667870769892, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=CN, orderNo=5, keyword=抗肿瘤), Keyword(id=1322634667988210405, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=EN, orderNo=1, keyword=homoharringtonine), Keyword(id=1322634668143399654, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=EN, orderNo=2, keyword=triptolide), Keyword(id=1322634668227285735, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=EN, orderNo=3, keyword=prostate cancer), Keyword(id=1322634668290200296, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=EN, orderNo=4, keyword=targeted nanoparticle), Keyword(id=1322634668365697769, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631254516810415, language=EN, orderNo=5, keyword=anti-tumor)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1302309778002903112, delFlag=0, nameCn=中草药, nameEn=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, issn=0253-2670, eissn=null, cn=12-1108/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=cGpSKCP11AF8PAOcTXYWfg==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Traditional and Herbal Drugs, journalRemark=null, publicationField=null, createdTime=1788424446827, updatedTime=1788949289390, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=cGpSKCP11AF8PAOcTXYWfg==, picEn=Xw//kxUC3ON4eHxev0QLhQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1304511127375863983, language=CN, name=中草药, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289411, updatedTime=1788949289411, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304511127442972848, language=EN, name=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289427, updatedTime=1788949289427, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1302319053441957962, websiteList=[Website(id=1302319176408912052, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/CN, language=CN, createTime=1788426687576, createBy=18614031015, updateTime=1788427346252, updateBy=18614031015, name=中草药-中文, tplId=1146099689490845704, title=中草药, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322043651904087, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=articleTextType, value=kx, createTime=1788427371180, updateTime=1788427371180, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043593183828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=banner, value=null, createTime=1788427371166, updateTime=1788427371166, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043672875610, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=grayFlag, value=0, createTime=1788427371185, updateTime=1788427371185, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043584795219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427371164, updateTime=1788427371164, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043689652828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=minRunFlag, value=0, createTime=1788427371189, updateTime=1788427371189, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043643515478, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic, createTime=1788427371178, updateTime=1788427371178, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043681264219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=silenceFlag, value=0, createTime=1788427371187, updateTime=1788427371187, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043601572437, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1788427371168, updateTime=1788427371168, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043660292696, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeColor, value=null, createTime=1788427371182, updateTime=1788427371182, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043668681305, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeStyle, value=null, createTime=1788427371184, updateTime=1788427371184, creator=18614031015, updator=18614031015)]), Website(id=1302319176715096246, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/EN, language=EN, createTime=1788426687649, createBy=18614031015, updateTime=1788427341161, updateBy=18614031015, name=中草药-英文, tplId=1146101810881728533, title=Chinese Traditional and Herbal Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322015206134340, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=articleTextType, value=kx, createTime=1788427364398, updateTime=1788427364398, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015185162817, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=banner, value=null, createTime=1788427364393, updateTime=1788427364393, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015227105863, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=grayFlag, value=0, createTime=1788427364403, updateTime=1788427364403, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015176774208, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427364391, updateTime=1788427364391, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015239688777, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=minRunFlag, value=0, createTime=1788427364406, updateTime=1788427364406, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015201940035, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic, createTime=1788427364397, updateTime=1788427364397, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015235494472, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=silenceFlag, value=0, createTime=1788427364405, updateTime=1788427364405, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015193551426, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1788427364395, updateTime=1788427364395, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015214522949, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeColor, value=null, createTime=1788427364400, updateTime=1788427364400, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015218717254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeStyle, value=null, createTime=1788427364401, updateTime=1788427364401, creator=18614031015, updator=18614031015)])], journalTitle=中草药, weixinUrl=null, journalUrl=https://www.tiprpress.com/zcy, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Traditional and Herbal Drugs, journalPhotoCn=cGpSKCP11AF8PAOcTXYWfg==, journalPhotoEn=Xw//kxUC3ON4eHxev0QLhQ==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.18.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2026.18.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/PDF/10.7501/j.issn.0253-2670.2026.18.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/PDF/10.7501/j.issn.0253-2670.2026.18.017, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1790524800000, fullTextJson=null, articleText=null, reference=Zhang Z J, Zhang W T, Wang H, et al. Immunosuppressive role of benzo[a]pyrene exposure in prostate cancer progression [J]. J Environ Sci, 2025, 156: 185-199.
Pandey S N, Moglad E, Gupta G, et al. Creatine kinase in prostate cancer: A biosensor-driven diagnostic paradigm [J]. Clin Chim Acta, 2025, 576: 120402.
邱衍怡, 周晓辉. 去势抵抗性前列腺癌(CRPC)的形成机制及其免疫治疗研究进展[J]. 药学研究, 2024, 43(7): 671-676.
黄晨超, 包旗旗, 张荣玉, 等. 新型抗前列腺癌药物ODM-201的研究进展[J]. 药学研究, 2021, 40(6): 351-358.
刘重远. Eya2在前列腺癌中过表达,通过Akt/Bcl-2通路调控前列腺癌细胞线粒体功能及多西紫杉醇敏感性[D]. 沈阳: 中国医科大学, 2020.
Chen C, Wang Q W, Liu J W. Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells via IGF-1/PI3K/Akt pathway [J]. J Int Med Res, 2025, 53(2): 03000605231220807.
韩静, 包纯洁, 段嘉伦. 中药活性成分作为药物递送纳米载体的研究进展[J]. 中草药, 2024, 55(16): 5678-5691.
Wang W, He L, Lin T, et al. Homoharringtonine: Mechanisms, clinical applications and research progress [J]. Front Oncol, 2025, 15: 1522273.
杜玉梅, 唐加峰, 黄世莹, 等. 高三尖杉酯碱激活ATM/p53通路抑制人肝癌细胞PLC5增殖[J]. 中国药理学通报, 2021, 37(3): 380-385.
郑肖庆, 丁樱, 王龙, 等. 雷公藤改善IgA血管炎性肾炎肾损伤的作用机制研究进展[J]. 中草药, 2025, 56(24): 9185-9196.
张俊强, 万久恺, 姚浩宇, 等. 雷公藤甲素通过miR-320bAR轴对前列腺癌细胞的抑制作用[J]. 西北药学杂志, 2022, 37(1): 65-70.
王锋, 张超, 郑栓. 具有线粒体靶向性的雷公藤甲素TPP-PEG-PCL脂质体的制备及其促肝肿瘤细胞凋亡研究[J]. 中草药, 2021, 52(24): 7473-7483.
Zhang X Y, Li Z H, Liu J Y, et al. Organoid-based drug screening identifies homoharringtonine as a therapeutic agent for anaplastic thyroid cancer via TFEB-mediated lysosomal dysfunction [J]. Cell Oncol, 2025, 49(1): 5.
张永基, 俞慧, 骆雪缨, 等. 三尖杉酯碱和高三尖杉酯碱的毒性[J]. 药学学报, 1979, 14(3): 135-40.
潘祥, 王均伟, 胡立宏. 雷公藤甲素前药的研究进展[J]. 南京中医药大学学报, 2020, 36(5): 684-689.
Kang D, Liu Y, Song Y, et al. Triptolide shows high sensitivity and low toxicity against acute myeloid leukemia cell lines through inhibiting WSTF-RNAPII complex [J]. Front Oncol, 2022, 12: 811850.
王如梦, 张宁, 刘阳, 等. PSMA基因表达对前列腺癌细胞生物学行为的影响及作用机制研究[J]. 局解手术学杂志, 2025, 34(11): 943-949.
秦灿, 梁爱玲, 刘勇军. 纳米载体在抗癌肽递送中的应用[J]. 中国生物化学与分子生物学报, 2025, 41(6): 833-842.
Sun L, Zuo C, Ma B, et al. Intratumoral injection of two dosage forms of paclitaxel nanoparticles combined with photothermal therapy for breast cancer [J]. Chin Herb Med, 2025, 17(1): 156-165.
Puik J R, Le C, Kazemier G, et al. Prostate-specific membrane antigen as target for vasculature-directed therapeutic strategies in solid tumors [J]. Crit Rev Oncol, 2025, 205: 104556.
Nezİr A E, Bolat Z B, Saka O M, et al. PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted BikDDA delivery to prostate cancer [J]. Turk J Biol, 2024, 48(3): 174-181.
Xu Y, Liu Y L, Liu Q, et al. Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy [J]. J Control Release, 2021, 338: 705-718.
袁辉, 衣琪昆, 李士壮, 等. 载小白菊内酯靶向脂质体的制备及体外抗肿瘤研究[J]. 药学研究, 2024, 43(11): 1045-1052.
李鑫, 刘佳艳, 元小红, 等. 雷公藤内酯醇联合高三尖杉酯碱对KG-1α细胞增殖和凋亡的影响[J]. 中国实验血液学杂志, 2018, 26(2): 347-353.
Wang J, Yuan H, Xu J N, et al. Advances in PSMA-targeted radionuclide therapy for metastatic castration-resistant prostate cancer [J]. Cancer Manag Res, 2025, 17: 1859-1869.
Li Q X, Xia D N, Tao J S, et al. Self-assembled core-shell-type lipid-polymer hybrid nanoparticles: Intracellular trafficking and relevance for oral absorption [J]. J Pharm Sci, 2017, 106(10): 3120-3130.)
收藏切换
共载高三尖杉酯碱/雷公藤甲素的靶向纳米粒制备及体外抗肿瘤评价
收藏切换
PDF下载
孙承文, 王帅, 章民昊, 李文超, 王艳春, 顾鹏
中草药 | 药剂与工艺 2026,57(18): 7281-7294
收起
收藏切换
中草药 |药剂与工艺 2026 , 57 (18) : 7281 -7294
共载高三尖杉酯碱/雷公藤甲素的靶向纳米粒制备及体外抗肿瘤评价
全屏
[Author(id=1324152561338561516, tenantId=1146029695717560320, journalId=null, articleId=1322631254516810415, orderNo=null, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=null, authorType=null, ext={EN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1322631254516810415, authorId=1324152561338561516, language=EN, stringName=SUN Chengwen, WANG Shuai, ZHANG Minhao, LI Wenchao, WANG Yanchun, GU Peng, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1322631254516810415, authorId=1324152561338561516, language=CN, stringName=孙承文, 王帅, 章民昊, 李文超, 王艳春, 顾鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=null)]
孙承文, 王帅, 章民昊, 李文超, 王艳春, 顾鹏
作者信息
通讯作者:
顾鹏
作者简介:
孙承文: 孙承文,男,副主任医师,研究方向为泌尿系肿瘤。E-mail:awen1698@126.com
Preparation and in vitro anti-tumor evaluation of targeted nanoparticles co-loaded with homohardenine/triptolide
SUN Chengwen, WANG Shuai, ZHANG Minhao, LI Wenchao, WANG Yanchun, GU Peng
Affiliations
    1 Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi 214062, China;
    2 Department of Urology, Xishan People's Hospital of Wuxi City, Wuxi 214105, China;
    3 Department of Urology, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China;
    4 The Rehabilitation Center of the Third Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450003, China
doi: 10.7501/j.issn.0253-2670.2026.18.017
文章导航
收藏切换
目的 制备共载高三尖杉酯碱(homoharringtonine,HHT)和雷公藤甲素(triptolide,TRL)-前列腺特异性膜抗原(prostate specific membrane antigen,PSMA)靶向肽修饰脂质-聚合物纳米粒(PSMA-targeting peptide-modified lipid-polymer nanoparticles co-loaded with HHT and TRL,HHT/TRL-PSMA-Lips),优化其制备工艺,并进行体外抗前列腺癌肿瘤作用评价。方法 测定HHT与TPL的溶解度及油水分配系数(lgP),合成PSMA靶向肽修饰PEG化磷脂。采用乳化-溶剂挥发法制备HHT/TPL-PSMA-Lips,采用中心复合设计-响应面法(central composite design-response surface methodology,CCD-RSM)优化处方,并考察其粒径、ζ电位、包封率等指标。考察制剂在不同介质中的体外释放行为。并采用MTT法、流式细胞术考察纳米粒对前列腺癌细胞的体外抑制及诱导凋亡作用,采用细胞摄取实验考察纳米粒的肿瘤细胞靶向效果。结果 HHT与TPL在不同介质中的溶解度均较低,亲脂性较强。合成PSMA靶向肽修饰PEG化磷脂的相对分子质量为4 643.8。采用最优处方的制备的HHT/TPL-PSMA-Lips粒径均一,平均粒径为(209.12±3.24)nm,ζ电位为(-34.4±2.5)mV,综合包封率为(81.20±0.40)%[HHT(80.73±0.86)%,TPL(82.00±0.40)%],体外释放实验证明,HHT/TPL-PSMA-Lips可有效提高HHT和TPL的溶解度,并具有一定的pH响应性释放效果。细胞实验表明,HHT/TPL联合给药组显示出高于单一药物组的前列腺肿瘤细胞抑制作用,及诱导凋亡效果,HHT/TPL-Lips可提高抗肿瘤活性,靶向修饰的纳米粒HHT/TPL-PSMA-Lips显示出对前列腺肿瘤细胞最强的抑制效果。细胞摄取实验表明,PSMA靶向肽的修饰可有效提高纳米制剂在肿瘤细胞的摄取。结论 制备的HHT/TPL-PSMA-Lips不仅可解决药物的溶解性问题,并可显著提升肿瘤靶向作用以及抗肿瘤效果,为中药新制剂用于前列腺癌的治疗提供了新思路。
高三尖杉酯碱  /  雷公藤甲素  /  前列腺癌  /  靶向纳米粒  /  抗肿瘤
Objective To prepare prostate specific membrane antigen (PSMA)-targeting peptide-modified lipid-polymer nanoparticles co-loaded with homoharringtonine and triptolide (HHT/TPL-PSMA-Lips), optimize its preparation process, and evaluate its in vitro anti-prostate cancer activity. Methods The solubility and oil-water partition coefficient (lgP) of HHT and TPL were determined, and PSMA-targeting peptide-modified PEGylated phospholipids were synthesized. HHT/TPL-PSMA-Lips was prepared by the emulsification-solvent evaporation method, and the formulation was optimized using central composite design-response surface methodology (CCD-RSM). Indicators including particle size, ζ potential, and encapsulation efficiency were investigated. The in vitro release behavior of the formulation in different media was evaluated. MTT assay and flow cytometry were used to assess the in vitro inhibitory effect and apoptosis-inducing activity of the nanoparticles on prostate cancer cells, while cell uptake assay was performed to verify the tumor cell targeting efficiency of the nanoparticles. Results HHT and TPL showed low solubility in various media and strong lipophilicity. The molecular weight of the synthesized PSMA-targeting peptide-modified PEGylated phospholipids was 4 643.8. HHT/TPL-PSMA-Lips prepared with the optimal formulation exhibited uniform particle size, with an average particle size of (209.12 ± 3.24) nm, a ζ potential of (-34.4 ± 2.5) mV, and a comprehensive encapsulation efficiency of (81.20 ± 0.40)% [HHT (80.73 ± 0.86)%, TPL (82.00 ± 0.40)%]. In vitro release experiments demonstrated that HHT/TPL-PSMA-Lips could effectively improve the solubility of HHT and TPL, and exhibite a certain pH-responsive release property. Cell experiments showed that the HHT/TPL combined administration group displayed stronger inhibitory effect on prostate cancer cells and better apoptosis-inducing activity than the single drug groups. HHT/TPL-Lips enhanced the anti-tumor activity, and the targeted modified nanoparticles (HHT/TPL-PSMA-Lips) showed the strongest inhibitory effect on prostate cancer cells. Cell uptake assay indicated that modification with PSMA-targeting peptide could effectively enhance the cellular uptake of the nanoformulation in tumor cells. Conclusion The prepared HHT/TPL-PSMA-Lips not only solves the solubility problem of the drugs but also significantly enhances tumor targeting and anti-tumor efficacy, providing a new approach for the development of new traditional Chinese medicine formulations for the treatment of prostate cancer.
homoharringtonine  /  triptolide  /  prostate cancer  /  targeted nanoparticle  /  anti-tumor
孙承文, 王帅, 章民昊, 李文超, 王艳春, 顾鹏. 共载高三尖杉酯碱/雷公藤甲素的靶向纳米粒制备及体外抗肿瘤评价. 中草药, 2026 , 57 (18) : 7281 -7294 . DOI: 10.7501/j.issn.0253-2670.2026.18.017
SUN Chengwen, WANG Shuai, ZHANG Minhao, LI Wenchao, WANG Yanchun, GU Peng. Preparation and in vitro anti-tumor evaluation of targeted nanoparticles co-loaded with homohardenine/triptolide[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (18) : 7281 -7294 . DOI: 10.7501/j.issn.0253-2670.2026.18.017

    国家自然科学基金资助项目 (U1804181); 河南省中医药专项课题 (2024ZY2134); 无锡市卫生健康委科研青年项目 (Q202307); 无锡市卫生健康委中青年后备拔尖人才项目 (HB2023117); 中国博士后科学基金第73批面上资助 (2023M730572)

参考文献 引证文献
排序方式:
Zhang Z J, Zhang W T, Wang H, et al. Immunosuppressive role of benzo[a]pyrene exposure in prostate cancer progression [J]. J Environ Sci, 2025, 156: 185-199.
Pandey S N, Moglad E, Gupta G, et al. Creatine kinase in prostate cancer: A biosensor-driven diagnostic paradigm [J]. Clin Chim Acta, 2025, 576: 120402.
邱衍怡, 周晓辉. 去势抵抗性前列腺癌(CRPC)的形成机制及其免疫治疗研究进展[J]. 药学研究, 2024, 43(7): 671-676.
黄晨超, 包旗旗, 张荣玉, 等. 新型抗前列腺癌药物ODM-201的研究进展[J]. 药学研究, 2021, 40(6): 351-358.
刘重远. Eya2在前列腺癌中过表达,通过Akt/Bcl-2通路调控前列腺癌细胞线粒体功能及多西紫杉醇敏感性[D]. 沈阳: 中国医科大学, 2020.
Chen C, Wang Q W, Liu J W. Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells via IGF-1/PI3K/Akt pathway [J]. J Int Med Res, 2025, 53(2): 03000605231220807.
韩静, 包纯洁, 段嘉伦. 中药活性成分作为药物递送纳米载体的研究进展[J]. 中草药, 2024, 55(16): 5678-5691.
Wang W, He L, Lin T, et al. Homoharringtonine: Mechanisms, clinical applications and research progress [J]. Front Oncol, 2025, 15: 1522273.
杜玉梅, 唐加峰, 黄世莹, 等. 高三尖杉酯碱激活ATM/p53通路抑制人肝癌细胞PLC5增殖[J]. 中国药理学通报, 2021, 37(3): 380-385.
郑肖庆, 丁樱, 王龙, 等. 雷公藤改善IgA血管炎性肾炎肾损伤的作用机制研究进展[J]. 中草药, 2025, 56(24): 9185-9196.
张俊强, 万久恺, 姚浩宇, 等. 雷公藤甲素通过miR-320bAR轴对前列腺癌细胞的抑制作用[J]. 西北药学杂志, 2022, 37(1): 65-70.
王锋, 张超, 郑栓. 具有线粒体靶向性的雷公藤甲素TPP-PEG-PCL脂质体的制备及其促肝肿瘤细胞凋亡研究[J]. 中草药, 2021, 52(24): 7473-7483.
Zhang X Y, Li Z H, Liu J Y, et al. Organoid-based drug screening identifies homoharringtonine as a therapeutic agent for anaplastic thyroid cancer via TFEB-mediated lysosomal dysfunction [J]. Cell Oncol, 2025, 49(1): 5.
张永基, 俞慧, 骆雪缨, 等. 三尖杉酯碱和高三尖杉酯碱的毒性[J]. 药学学报, 1979, 14(3): 135-40.
潘祥, 王均伟, 胡立宏. 雷公藤甲素前药的研究进展[J]. 南京中医药大学学报, 2020, 36(5): 684-689.
Kang D, Liu Y, Song Y, et al. Triptolide shows high sensitivity and low toxicity against acute myeloid leukemia cell lines through inhibiting WSTF-RNAPII complex [J]. Front Oncol, 2022, 12: 811850.
王如梦, 张宁, 刘阳, 等. PSMA基因表达对前列腺癌细胞生物学行为的影响及作用机制研究[J]. 局解手术学杂志, 2025, 34(11): 943-949.
秦灿, 梁爱玲, 刘勇军. 纳米载体在抗癌肽递送中的应用[J]. 中国生物化学与分子生物学报, 2025, 41(6): 833-842.
Sun L, Zuo C, Ma B, et al. Intratumoral injection of two dosage forms of paclitaxel nanoparticles combined with photothermal therapy for breast cancer [J]. Chin Herb Med, 2025, 17(1): 156-165.
Puik J R, Le C, Kazemier G, et al. Prostate-specific membrane antigen as target for vasculature-directed therapeutic strategies in solid tumors [J]. Crit Rev Oncol, 2025, 205: 104556.
Nezİr A E, Bolat Z B, Saka O M, et al. PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted BikDDA delivery to prostate cancer [J]. Turk J Biol, 2024, 48(3): 174-181.
Xu Y, Liu Y L, Liu Q, et al. Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy [J]. J Control Release, 2021, 338: 705-718.
袁辉, 衣琪昆, 李士壮, 等. 载小白菊内酯靶向脂质体的制备及体外抗肿瘤研究[J]. 药学研究, 2024, 43(11): 1045-1052.
李鑫, 刘佳艳, 元小红, 等. 雷公藤内酯醇联合高三尖杉酯碱对KG-1α细胞增殖和凋亡的影响[J]. 中国实验血液学杂志, 2018, 26(2): 347-353.
Wang J, Yuan H, Xu J N, et al. Advances in PSMA-targeted radionuclide therapy for metastatic castration-resistant prostate cancer [J]. Cancer Manag Res, 2025, 17: 1859-1869.
Li Q X, Xia D N, Tao J S, et al. Self-assembled core-shell-type lipid-polymer hybrid nanoparticles: Intracellular trafficking and relevance for oral absorption [J]. J Pharm Sci, 2017, 106(10): 3120-3130.
2026年第57卷第18期
PDF下载
31
7
引用本文
BibTeX
文章信息
doi: 10.7501/j.issn.0253-2670.2026.18.017
  • 接收时间:2026-03-20
  • 首发时间:2026-10-29
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-03-20
基金
作者信息
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.18.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏